Platform

Ace Therapeutics is a contract service provider focusing on parasitology research, we are committed to providing a full range of parasitology research services and solutions to our clients. As an industry leader, we have established a well-developed cutting-edge technology platform and are always at the forefront of parasitology research as technology continues to evolve and update.

Currently, we have six core technology platforms. Among them, the parasite detection technology platform can detect and identify a variety of parasites quickly and efficiently, and can meet the various needs of customers for parasite detection. Parasite sequencing technology platform can realize in-depth research on parasite genome and transcriptome, providing more comprehensive parasitological research services to our customers.

In addition, we also have a parasite genetic engineering technology platform, which enables the editing and modification of parasite genes to explore the functions and mechanisms of action of parasites. Parasite microscopic imaging technology platform can provide customers with high-quality images and video materials of parasites, helping researchers to study the morphological, structural and behavioral aspects of parasites in greater depth.

In addition, we have a parasite culture platform to provide high quality and stable parasite culture services to meet our customers' needs for parasite culture. Finally, we also have a parasite drug development technology platform to support our customers in parasite drug research and development, including evaluation of efficacy, resistance and toxic side effects.

In conclusion, Ace Therapeutics has established a complete cutting-edge technology platform to follow the trend and be at the forefront of parasitology research by constantly updating and upgrading our technology. We will continue to innovate and collaborate to make greater contributions to the advancement of global parasitology research.